Column: Solid science, and Dr. Anthony Fauci, are essential during this pandemic - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
April 3, 2020 Newswires
Share
Share
Post
Email

Column: Solid science, and Dr. Anthony Fauci, are essential during this pandemic

Chicago Tribune (IL)

A few decades ago, I noticed that my aging father, who loathed all jewelry besides his wedding ring, was wearing a copper bracelet.

“It’s supposed to be good for aches and pains,” he muttered, sounding a bit less than convinced of its alleged powers.

“Y’know that’s probably not going to do you any good,” I said, seizing this golden opportunity to show that his help with my college costs had not gone to waste.

“Well,” he said with a shrug, “it’s probably not going to do me any harm either.”

Also true. As I later confirmed through a little library research, there is scant evidence of any medicinal impact of copper bracelets, except perhaps turning your wrist green.

Unfortunately, not all such disputes over alleged wonder cures are so easily resolved.

The rise of the coronavirus pandemic in our American age of social networks and sociopolitically polarized everything has led to an explosive mix of facts, falsehoods, rumors, snake oil sales and paranoid alternative realities, all preying on public fear and desperation.

Although this is hardly the first time that an information crisis has broken out within a larger, sweeping public health crisis, one is hard-pressed to recall one in which the nation’s president is this deeply supportive of the untested miracle cure side of the debate as President Donald Trump has been.

The contrast came into full public view at the president’s March 20 daily coronavirus press briefing when reporters asked about chloroquine, a drug typically used for malaria that Trump touted earlier in the week as a possible treatment for COVID-19, the disease caused by the virus.

After Trump praised chloroquine again, Dr. Anthony Fauci, the widely respected head of the National Institute of Allergy and Infectious Diseases, politely stepped up to the microphones to caution that evidence supporting chloroquine as safe and effective against COVID-19 is thin and anecdotal until clinical trials can be conducted.

It’s hard to argue with Fauci, who has held his post through administrations of both parties since the early 1980s. But Trump stepped back up to give it a try.

“I’m probably more of a fan of that -- maybe than anybody,” he said. “But I’m a big fan, and we’ll see what happens. We all understand what the doctor (Fauci) said is 100% correct: It’s early. But I have seen things that are impressive. We’ll see. We’re gonna know soon.”

I have often said that if I ever write a book on Trump’s presidency, the perfect title might well be, “We’ll See What Happens.” It seems to be his most-used conversational closer, regardless of the topic.

But this time he continued: “I feel good about it. That’s all it is: Just a feeling. I’m a smart guy.”

Right. As my copper bracelet-wearing dad used to say, whenever somebody tells you how smart they are, they probably aren’t.

Still, Trump capped it off in familiar fashion: “I’ve been right a lot. Let’s see what happens.”

Yes, let’s. Unfortunately, there are a lot of people who don’t want to wait.

Dr. Vladimir Zelenko, a New York family doctor, got this national conversation started after treating people with coronavirus-like symptoms with an experimental treatment that includes the anti-malarial medication hydroxychloroquine, a less-toxic derivative of chloroquine.

Sean Hannity, Fox News host and close Trump friend, promoted Zelenko’s claims on his TV and radio shows. Mark Meadows, incoming White House chief of staff, called Zelenko to get more information. Rudy Giuliani also praised him in a podcast interview, and Trump began to promote it as “very effective” and possibly “the biggest game changer in the history of medicine,” despite the lack of proper testing and research to support that.

Still, self-described “smart guy” Trump has been smart enough to keep Fauci on his coronavirus task force, despite some loony claims by paranoid right wing and, I would argue, anti-science conspiracy theorists.

The wing nuts suspect or claim to suspect Fauci, a leading expert and advocate of social distancing, is secretly trying to undermine Trump’s reelection chances. In fact, he’s a major asset in Trump’s effort to stop the virus and keep his job.

But don’t expect rational thinking from the paranoid right or left. The threats have led to Fauci’s receiving enough death threats to be assigned enhanced personal security. Asked about it, he bravely shrugged off the threats and security as an unfortunate part of his job. But he deserves better. Much better.

Clarence Page, a member of the Tribune Editorial Board, blogs at www.chicagotribune.com/pagespage.

cpage@chicagotribune.com

Twitter @cptime

___

(c)2020 the Chicago Tribune

Visit the Chicago Tribune at www.chicagotribune.com

Distributed by Tribune Content Agency, LLC.

Older

Out-of-State Victims Suffer Injuries in Tulsa, OK Auto Accident

Advisor News

  • U.S. debt hits $40 trillion: how to support concerned clients
  • Flourish brings private-bank-like cash solution to MassMutual’s network
  • Majority of Americans concerned recent market highs are unsustainable
  • GLP-1 users choose between medication and retirement saving
  • Gen X and millennials seek new retirement model
More Advisor News

Annuity News

  • Corebridge Financial Introduces Progressive Trigger, a First-of-Its-Kind Index Annuity Strategy Designed to Turn Missed Years into Future Opportunity
  • Insurer proposes $1.1M deal to resolve CA teachers’ annuity fee lawsuit
  • IMOs get frustrated with slow carrier adoption of faster technology
  • New class-action lawsuit targets Delaware Life over annuity disclosures
  • A client remarried: Does their annuity still fit?
More Annuity News

Health/Employee Benefits News

  • What 70% doesn’t tell you
  • Blue Cross faces Michigan lawsuit over alleged monopoly and pricing practices
  • SMH, UnitedHealthcare wrangle over coverage
  • Millions lose private Medicare plans and face rising costs
  • State announces rates for 2027 small group health insurance market
Sponsor
More Health/Employee Benefits News

Life Insurance News

  • Corebridge Financial Introduces Progressive Trigger, a First-of-Its-Kind Index Annuity Strategy Designed to Turn Missed Years into Future Opportunity
  • BILTIR conference draws more than 750 insurance leaders to Bermuda
  • Death and taxes: How the right analysis for life insurance changes the picture
  • Life insurance applications rise 15.2% in September, MIB reports
  • Flourish brings private-bank-like cash solution to MassMutual’s network
Sponsor
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Lauren Sinnott Named to Ragan’s Top Women in Marketing Awards, Class of 2026 
  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
  • How Aspire General Turned an Early Technology Bet Into Claims Automation at Scale with Kyber
  • Adjusto launches AI-Native contents claims services powered by its technology platform
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.